SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-039417
Filing Date
2023-06-23
Accepted
2023-06-23 16:37:32
Documents
1
Period of Report
2023-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4044
  Complete submission text file 0001209191-23-039417.txt   5464
Mailing Address INSPIRE PHARMACEUTICALS, INC., 4222 EMPEROR BLVD., STE. 470 DURHAM NC 27703-8466
Business Address
SHAFFER CHRISTY L (Reporting) CIK: 0001145929 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37783 | Film No.: 231038281

Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Issuer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations